SynthesisActa neurochirurgica2021
Metastases to meningioma-review and meta-analysis.
Synthesis in Acta neurochirurgica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 28 citations in OpenAlex.
- Tumor-to-tumor metastasis of small cell carcinoma of presumed pulmonary origin to a sphenoid ridge meningioma: A diagnostic pitfall in preoperative systemic evaluation.Surgical neurology international · 2026Article
- Article
- Article
- Collision tumor, a metastatic melanoma within a meningioma: a case report.Acta neuropathologica communications · 2025Article
- Tumor-to-tumor metastasis of clear cell renal cell carcinoma to meningioma: illustrative case.Journal of neurosurgery. Case lessons · 2025Article
- Recommendations on the management of meningioma and sex hormone therapy: The results of a collaborative effort between neurosurgical, endocrine and gynecological societies.Brain & spine · 2025Article
- Metastatic Temporal Bone Tumor From Renal Cell Carcinoma Coexisting With Sphenoid Ridge Meningioma: A Case Report.Cureus · 2024Article
- Metastasis infiltrating tumor to meningioma: a case report.Journal of medical case reports · 2024Article
- Review of metastasis to meningiomas with case examples.Brain & spine · 2024Article
- Left dural-based mass in a 62-year-old female.Brain pathology (Zurich, Switzerland) · 2023Article
- Small-cell lung cancer metastasis to a meningioma: Case report and review of the literature.Radiology case reports · 2023Article
- Tumor-to-Tumor Metastases Involving Clear Cell Renal Cell Carcinomas: A Diagnostic Challenge for Pathologists Needing Clinical Correlation.Clinics and practice · 2023Article
- Case Report: Recurrent meningioma with multiple metastases.Frontiers in oncology · 2023Article
- Article
- Breast Cancer to Meningioma: A Rare Case of Tumor-to-Tumor Metastasis.Brain tumor research and treatment · 2023Article
- Multiple recurrences of unknown primary tumor in a meningioma: A case report.The neuroradiology journal · 2022Article
- Meningioma as the host for metastatic breast cancer: A rare occurrence with important therapeutic impact.Surgical neurology international · 2021Article
- Combination tumors of the nervous system: A single-center analysis of a rare condition and comprehensive review of the literature.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMeningiomas are a common tumor within the cranial cavity. They may be a target for metastatic spread of cancer elsewhere in the body. We analyzed all the data in the literature about tumor-to-meningioma metastasis (TTMM).
methodsWe performed a meta-analysis using the PRISMA checklist to locate all cases of TTMM in the PubMed and Medline databases. We collected patient and cancer parameters, meningioma parameters, and clinical factors.
resultsWe located 124 articles, describing 152 cases of patients with TTMM. The mean (± SD) age of all patients was 62.21 ± 10.8 years, with even distribution above and below the mean. Of the cases, 65.9% were reported in women. The most common cancer origins of TTMM were breast and lung carcinoma, followed by kidney, prostate, and GI tract carcinoma. Cancer status is not a good marker of TTMM when managing a meningioma. In 36.69% of cases, TTMM was the presentation of an unknown cancer. In nearly 60% of the known cases, cancer was considered in remission for at least 1 year. Meningioma parameters are unhelpful when considering a TTMM. The distribution of meningioma location is similar to other series of meningioma reported in the literature. Meningioma grade is similar to meningiomas without TTMM. In 57.89%, the patient presented with a focal deficit. Presenting factors were seizures, elevated ICP, and others. Over 95% of cases were symptomatic at presentation.
conclusionTTMM should be suspected in cases of meningioma in a patient with background cancer, regardless of meningioma parameters or cancer status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.